U.S. Markets closed

BioScrip, Inc. -- Moody's upgrades BioScrip, Inc.'s Corporate Family Rating to B3, outlook stable

Moody's Investors Service ("Moody's") today upgraded the Corporate Family Rating (CFR) of BioScrip, Inc. ("BioScrip") to B3 from Caa1 and upgraded the Probability of Default to B3-PD from Caa1-PD. At the same time, Moody's upgraded the Speculative Grade Liquidity Rating to SGL-3 from SGL-4 and assigned a B2 (LGD 3) rating to the proposed $925 million First Lien Term Loan B. The outlook is stable. The upgrade reflects the improvement in BioScrip's credit profile due to the pending merger with HC Group Holdings III, Inc. (dba Option Care).